Quantification of skeletal involvement in adults with type I Gaucher's disease: Fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter

American Journal of Roentgenology

Volumn 179, Issue 4, 2002, Pages 961-965

  Maas, Mario ^a   Hollak, Carla E M ^a   Akkerman, Erik M ^a   Aerts, Johannes M F G ^a   Stoker, Jaap ^a   Den Heeten, Gerard J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; AVASCULAR NECROSIS; BONE EROSION; BONE MARROW; BONE PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIXON QUANTITATIVE CHEMICAL SHIFT IMAGING; FEMALE; GAUCHER DISEASE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; PATHOLOGIC FRACTURE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

EID: 0036783707     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.179.4.1790961     Document Type: Article

References (28)

1. Gaucher's PCE. De l'epithelioma primitif de la rate, hypertrophie idiopathique de la rate sans leukemie. Paris: Thesis, 1882
2. Cremin BJ, Davey H, Golblatt J. Skeletal complications of type 1 Gaucher disease: the magnetic resonance features. Clin Radiol 1990;41:244-247
3. Miller SPF, Zirzow GC, Doppelt SH, Brady RO, Barton NW. Analysis of the lipids of normal and Gaucher bone marrow. J Lab Clin Med 1996;127:353-358
4. Johnson LA, Hoppel BE, Gerard EL, et al. Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease. Radiology 1992;182:451-455
5. O'Keefe D, Rosenthal DI. Computed tomography and magnetic resonance imaging in Gaucher disease. In: Bloem JL, Sartoris DJ, eds. MRI and CT of the musculoskeletal system: a text-atlas. Baltimore: Williams & Wilkins, 1992:130-138
6. Rourke JA, Heslin DJ. Gaucher's disease: roentgenologic bone changes over 20-year interval. AJR 1965;94:621-630
7. Rodrique SW, Rosenthal DI, Barton NW, Zurakowski D, Mankin HJ. Risk factors for osteonecrosis in patients with type 1 Gaucher's disease. Clin Orthop 1999;362:201-207
8. Vogler JB III, Murphy WA. Bone marrow imaging. Radiology 1988;168:679-693
9. Rosenthal DI, Scott JA, Barranger J, et al. Evaluation of Gaucher disease using magnetic resonance imaging. J Bone Joint Surg Am 1986;68:802-808
10. Hermann G, Shapiro RS, Fikry Abdelwahab I, Grabowski G. MR imaging in adults with Gaucher disease type 1: evaluation of marrow involvement and disease activity. Skeletal Radiol 1993;22:247-251
11. Rosenthal DI, Barton NW, McKusick KA, et al. Quantitative imaging of Gaucher disease. Radiology 1992;185:841-845
12. Rosen BR, Fleming DM, Kushner DC, et al. Hematological bone marrow disorders: quantitative chemical shift MR imaging. Radiology 1988;169:799-804
13. Mankin HJ, Rosenthal DI, Xavier R. Gaucher disease: new approaches to an ancient disease. J Bone Joint Surg Am 2001;83:748-763
14. Rosenthal DI, Doppelt SH, Mankin HJ, et al. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics 1995;96:629-637
15. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153:189-194
16. Maas M, Akkerman EM, Venema HW, Stoker J, den Heeten GJ. Dixon quantitative chemical shift MR imaging for bone marrow evaluation in the lumbar spine: an evaluating study in healthy volunteers. J Comput Assist Tomogr 2001;25:691-697
17. Hollak CEM, Aerts JM, Goudsmit R, et al. Individualized low-dose alglucerase therapy for type 1 Gaucher's disease. Lancet 1995;345:1474-1478
18. Maas M, Akkerman EM, Hollak CEM, Rademakers RP. Evaluation of skeletal involvement in M. Gaucher: use of quantitative chemical shift imaging (QCSI). Eur Radiol 1997;7[suppl]:S206
19. Sibille A, Eng CM, Kim S-J, Pastores G, Grabowski GA. Phenotype/genotype correlations in Gaucher disease type 1: clinical and therapeutic implications. Am J Hum Genet 1993;52:1094-1101
20. Sidransky E, Girins EI. Phenotypic and genotypic heterogeneity in Gaucher disease: implications for genetic counseling. J Genet Counsel 1994;3:13-22
21. Boot RG, Hollak CEM, Verhoek M, et al. Glucocerebrosidase genotype of Gaucher patients in the Netherlands: limitations in prognostic value. Hum Mutat 1997;10:348-358
22. Maas M, Dijkstra PF, Akkerman EM. Uniform fat-suppression in hands and feet through the use of two-point dixon chemical shift imaging. Radiology 1999;210:189-193
23. Akkerman EM, Maas M. A region-growing algorithm to simultaneously remove dephasing influences and separate fat and water in two-point Dixon imaging. Proceedings of the Society of Magnetic Resonance and the European Society for Magnetic Resonance in Medicine and Biology. Nice, France: Society of Magnetic Resonance, 1995:649
24. Aerts JH, Hollak CEM. Plasma and metabolic abnormalities in Gaucher disease. Bailliere's clinical haematology. 1997;10:691-709
25. Hollak C, Maas M, Akkerman E, den Heeten A, Aerts H. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease. Blood Cells Mol Dis 2001;27:1005-1012
26. Cristy M. Active bone marrow distribution as a function of age in humans. Phys Med Biol 1981;26:389-400
27. Ishijima H, Ishizaka H, Horikoshi H, Sakurai M. Water fraction of lumbar vertebral bone marrow estimated from chemical shift misregistration on MR imaging: normal variations with age and sex. AJR 1996;167:355-358
28. Rozman C, Feliu E, Berga L, Reverter JC, Climent C, Ferran MJ. Age-related variations of fat tissue fractions in normal human marrow depend both on size and number of adipocytes: a stereological study. Exp Hematol 1989;17:34-37